Enhancing tetrandrine cytotoxicity in human lung carcinoma A549 cells by suppressing mitochondrial ATP production. 2019

Louis W C Chow, and Ka-Shun Cheng, and Fai Leong, and Chi-Wai Cheung, and Lian-Ru Shiao, and Yuk-Man Leung, and Kar-Lok Wong
State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China.

ATP depletion induced by inhibiting glycolysis or mitochondrial ATP production has been demonstrated to cause cancer cell death. Whether ATP depletion can enhance the efficacy and potency of anti-cancer effects of herbal compounds is so far unknown. We examined the enhancing effect of ATP depletion on anti-cancer actions of tetrandrine (TET) in human lung carcinoma A549 cells. A 24-h incubation of A549 cells with tetrandrine caused a concentration-dependent cytotoxic effect (LC50 = 66.1 μM). Co-incubation with 20 mM 2-deoxyglucose (2-DG, glycolysis inhibitor) caused only a very slight enhancement of tetrandrine cytotoxicity. By contrast, inhibiting mitochondrial ATP production with oligomycin (10 μM, ATP synthase inhibitor) and FCCP (30 μM, uncoupling agent) (thus, oligo-FCCP) on its own caused only slight cell cytotoxicity but strongly potentiated tetrandrine cytotoxicity (tetrandrine LC50 = 15.6 μM). The stronger enhancing effect of oligo-FCCP than 2-DG on TET toxicity did not result from more severe overall ATP depletion, since both treatments caused a similar ATP level suppression. Neither oligo-FCCP nor 2-DG synergized with tetrandrine in decreasing mitochondrial membrane potential. TET on its own triggered reactive oxygen species (ROS) production, and oligo-FCCP, but not 2-DG, potentiated TET in causing ROS production. Taken together, our results suggest that inhibiting ATP production from mitochondria, but not from glycolysis, appears to be a very effective means in augmenting TET-triggered ROS production and hence toxicity in A549 cells.

UI MeSH Term Description Entries
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072283 A549 Cells An immortalized cell line derived from human ADENOCARCINOMA, ALVEOLAR basal epithelial cells isolated from the lungs of a male patient in 1972. The cell line is positive for KERATIN, can synthesize LECITHIN, and contains high levels of POLYUNSATURATED FATTY ACIDS in its PLASMA MEMBRANE. It is used as a model for PULMONARY ALVEOLI function and virus infections, as a TRANSFECTION host, and for PRECLINICAL DRUG EVALUATION. A549 Cell Line,A549 Cell,A549 Cell Lines,Cell Line, A549,Cell Lines, A549,Cell, A549,Cells, A549
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D044182 Benzylisoquinolines ISOQUINOLINES with a benzyl substituent. Benzyl-Isoquinoline,Benzylisoquinoline,Bis-Benzyl-Isoquinoline,Bis-Benzylisoquinoline,Bisbenzylisoquinoline,Bisbenzylisoquinolines,Benzyl-Isoquinolines,Bis-Benzyl-Isoquinolines,Bis-Benzylisoquinolines,Benzyl Isoquinoline,Benzyl Isoquinolines,Bis Benzyl Isoquinoline,Bis Benzyl Isoquinolines,Bis Benzylisoquinoline,Bis Benzylisoquinolines

Related Publications

Louis W C Chow, and Ka-Shun Cheng, and Fai Leong, and Chi-Wai Cheung, and Lian-Ru Shiao, and Yuk-Man Leung, and Kar-Lok Wong
December 2002, International journal of oncology,
Louis W C Chow, and Ka-Shun Cheng, and Fai Leong, and Chi-Wai Cheung, and Lian-Ru Shiao, and Yuk-Man Leung, and Kar-Lok Wong
March 2009, Journal of veterinary science,
Louis W C Chow, and Ka-Shun Cheng, and Fai Leong, and Chi-Wai Cheung, and Lian-Ru Shiao, and Yuk-Man Leung, and Kar-Lok Wong
December 2020, Environmental toxicology,
Louis W C Chow, and Ka-Shun Cheng, and Fai Leong, and Chi-Wai Cheung, and Lian-Ru Shiao, and Yuk-Man Leung, and Kar-Lok Wong
March 2014, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery,
Louis W C Chow, and Ka-Shun Cheng, and Fai Leong, and Chi-Wai Cheung, and Lian-Ru Shiao, and Yuk-Man Leung, and Kar-Lok Wong
November 2020, Nanomaterials (Basel, Switzerland),
Louis W C Chow, and Ka-Shun Cheng, and Fai Leong, and Chi-Wai Cheung, and Lian-Ru Shiao, and Yuk-Man Leung, and Kar-Lok Wong
May 1990, Toxicology,
Louis W C Chow, and Ka-Shun Cheng, and Fai Leong, and Chi-Wai Cheung, and Lian-Ru Shiao, and Yuk-Man Leung, and Kar-Lok Wong
April 2018, Annals of translational medicine,
Louis W C Chow, and Ka-Shun Cheng, and Fai Leong, and Chi-Wai Cheung, and Lian-Ru Shiao, and Yuk-Man Leung, and Kar-Lok Wong
January 2020, Evidence-based complementary and alternative medicine : eCAM,
Louis W C Chow, and Ka-Shun Cheng, and Fai Leong, and Chi-Wai Cheung, and Lian-Ru Shiao, and Yuk-Man Leung, and Kar-Lok Wong
August 2007, Cancer chemotherapy and pharmacology,
Louis W C Chow, and Ka-Shun Cheng, and Fai Leong, and Chi-Wai Cheung, and Lian-Ru Shiao, and Yuk-Man Leung, and Kar-Lok Wong
October 2013, Cytokine,
Copied contents to your clipboard!